Atlas Trials

Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT02477215 · COMPLETED

Trial details

NCT number
NCT02477215
Sponsor
Parameswaran Hari
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2015-10-09
Primary completion
2018-05-02
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.